Association between exhaled volatile organic compounds and urinary levels of oral corticosteroids within the U-BIOPRED Cohort
P. Brinkman (Amsterdam, Netherlands), W. Ahmed (Manchester, United Kingdom), C. Gómez (Stockholm, Sweden), H. Knobel (Eindhoven, Netherlands), H. Weda (Eindhoven, Netherlands), T. Vink (Eindhoven, Netherlands), T. Nijsen (Eindhoven, Netherlands), C. Wheelock (Stockholm, Sweden), S. Dahlen (Stockholm, Sweden), P. Montuschi (Rome, Italy), R. Knowles (Stevenage, United Kingdom), S. Vijverberg (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), S. Fowler (Manchester, United Kingdom)
Source: International Congress 2018 – Biomarkers in COPD and asthma
Session: Biomarkers in COPD and asthma
Session type: Oral Presentation
Number: 3582
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Brinkman (Amsterdam, Netherlands), W. Ahmed (Manchester, United Kingdom), C. Gómez (Stockholm, Sweden), H. Knobel (Eindhoven, Netherlands), H. Weda (Eindhoven, Netherlands), T. Vink (Eindhoven, Netherlands), T. Nijsen (Eindhoven, Netherlands), C. Wheelock (Stockholm, Sweden), S. Dahlen (Stockholm, Sweden), P. Montuschi (Rome, Italy), R. Knowles (Stevenage, United Kingdom), S. Vijverberg (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), S. Fowler (Manchester, United Kingdom). Association between exhaled volatile organic compounds and urinary levels of oral corticosteroids within the U-BIOPRED Cohort. 3582
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: